Literature DB >> 1884290

Comparative hemodynamic effects of halothane and halothane-acepromazine at equipotent doses in dogs.

C J Boyd1, W N McDonell, A Valliant.   

Abstract

The purpose of this study was to compare the cardiovascular effects of halothane when used alone at increasing doses (1.2, 1.45 and 1.7 minimum alveolar concentration, MAC) to those produced with equipotent doses of halothane after potentiation of the anesthetic effect with acepromazine (ACP) sedation (45% reduction of halothane MAC). Six healthy mature dogs were used on three occasions. The treatments were halothane and intramuscular (IM) saline (1.0 mL), halothane and ACP (0.04 mg/kg IM), or halothane and ACP (0.2 mg/kg IM). Anesthesia was induced and maintained with halothane in oxygen and the dogs were prepared for the collection of arterial and mixed venous blood and for the determination of heart rate, systolic, diastolic and mean arterial pressure, mean pulmonary arterial pressure (PAP), central venous pressure and cardiac output. Following animal preparation the saline or ACP was administered and positive pressure ventilation instituted. Twenty-five minutes later the dogs were exposed to the first of three anesthetic levels, with random assignment of the sequence of administration. At each anesthetic level, measurements were obtained at 20 and 35 min. Calculated values included cardiac index, stroke index, left ventricular work, systemic vascular resistance, arterial oxygen content, mixed venous oxygen content, oxygen delivery and oxygen consumption. Heart rate was significantly higher with halothane alone than with both halothane-ACP combinations and was significantly higher with high dose ACP compared to low dose ACP. Systolic and mean blood pressures were lowest with halothane alone and highest with 0.2 mg/kg ACP, the differences being significant for each treatment. Oxygen uptake and PAP were significantly lower in dogs treated with ACP. It was concluded that ACP does not potentiate the cardiovascular depression that accompanies halothane anesthesia when the resultant lower dose requirements of halothane are taken into consideration.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1884290      PMCID: PMC1263428     

Source DB:  PubMed          Journal:  Can J Vet Res        ISSN: 0830-9000            Impact factor:   1.310


  18 in total

1.  Respiratory and cardiovascular effects of five drugs used as sedatives in the dog.

Authors:  D M Turner; J E Ilkiw; R J Rose; J M Warren
Journal:  Aust Vet J       Date:  1974-06       Impact factor: 1.281

2.  Acetylpromazine administration: its effect on canine haematology.

Authors:  S M Lang; R M Eglen; A C Henry
Journal:  Vet Rec       Date:  1979-10-27       Impact factor: 2.695

3.  Epidural morphine reduces halothane MAC in the dog.

Authors:  A Valverde; D H Dyson; W N McDonell
Journal:  Can J Anaesth       Date:  1989-11       Impact factor: 5.063

4.  The pharmacokinetics, pharmacological responses and behavioral effects of acepromazine in the horse.

Authors:  S Ballard; T Shults; A A Kownacki; J W Blake; T Tobin
Journal:  J Vet Pharmacol Ther       Date:  1982-03       Impact factor: 1.786

5.  Cardiovascular effects of halothane in the horse.

Authors:  E P Steffey; D Howland
Journal:  Am J Vet Res       Date:  1978-04       Impact factor: 1.156

6.  Potency of enflurane in dogs: comparison with halothane and isoflurane.

Authors:  E P Steffey; D Howland
Journal:  Am J Vet Res       Date:  1978-04       Impact factor: 1.156

7.  Influence of acepromazine maleate on the equine haematocrit.

Authors:  B W Parry; G A Anderson
Journal:  J Vet Pharmacol Ther       Date:  1983-06       Impact factor: 1.786

8.  Circulatory and respiratory effects of methoxyflurane in dogs: comparison of halothane.

Authors:  E P Steffey; T B Farver; M J Woliner
Journal:  Am J Vet Res       Date:  1984-12       Impact factor: 1.156

9.  Effect of acepromazine on the anesthetic requirement of halothane in the dog.

Authors:  D J Heard; A I Webb; R T Daniels
Journal:  Am J Vet Res       Date:  1986-10       Impact factor: 1.156

10.  Cardiopulmonary effects of acepromazine and of the subsequent administration of ketamine in the dog.

Authors:  T B Farver; S C Haskins; J D Patz
Journal:  Am J Vet Res       Date:  1986-03       Impact factor: 1.156

View more
  9 in total

1.  Evaluation of the arrhythmogenicity of a low dose of acepromazine: comparison with xylazine.

Authors:  D Dyson; G Pettifer
Journal:  Can J Vet Res       Date:  1997-10       Impact factor: 1.310

2.  Is it really true?

Authors:  D H Dyson
Journal:  Can Vet J       Date:  1993-08       Impact factor: 1.008

3.  Cardiorespiratory effects of a 5HT2 antagonist (R51703) in awake and anesthetized dogs.

Authors:  T J Doherty; W N McDonell; D H Dyson; W D Black
Journal:  Can J Vet Res       Date:  1996-07       Impact factor: 1.310

4.  Cardiopulmonary effects of romifidine/ketamine or xylazine/ketamine when used for short duration anesthesia in the horse.

Authors:  Carolyn L Kerr; Wayne N McDonell; Simon S Young
Journal:  Can J Vet Res       Date:  2004-10       Impact factor: 1.310

5.  Modification of cardiopulmonary and intestinal motility effects of xylazine with glycopyrrolate in horses.

Authors:  S Singh; S S Young; W N McDonell; M O'Grady
Journal:  Can J Vet Res       Date:  1997-04       Impact factor: 1.310

6.  Cardiopulmonary effects of hypercapnia during controlled intermittent positive pressure ventilation in the horse.

Authors:  A K Khanna; W N McDonell; D H Dyson; P M Taylor
Journal:  Can J Vet Res       Date:  1995-07       Impact factor: 1.310

7.  End tidal halothane concentration and postoperative analgesia requirements in dogs: a comparison between intravenous oxymorphone and epidural bupivacaine alone and in combination with oxymorphone.

Authors:  K E Torske; D H Dyson; G Pettifer
Journal:  Can Vet J       Date:  1998-06       Impact factor: 1.008

8.  Cardiopulmonary effects and recovery characteristics associated with 2 sedative protocols for assisted ventilation in healthy neonatal foals.

Authors:  Carolyn L Kerr; Stephanie C J Keating; Luis G Arroyo; Laurent Viel
Journal:  Can J Vet Res       Date:  2021-10       Impact factor: 1.310

9.  Effects of vatinoxan on cardiorespiratory function and gastrointestinal motility during constant-rate medetomidine infusion in standing horses.

Authors:  H Tapio; M R Raekallio; A Mykkänen; S Männikkö; M Scheinin; R C Bennett; O Vainio
Journal:  Equine Vet J       Date:  2019-03-14       Impact factor: 2.888

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.